Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 84,147

Document Document Title
WO/2014/040379A1
Provided are a biological bacterium, Wickerhamomyces anomalus, the use of same in preparing a textile cellulose, a cellulose for use as an additive, and a biological bacterial solution pulp, and application methods therefor. The deposit ...  
WO/2014/042209A1
[Problem] To provide novel peptides having a high binding capacity to the epithelial cell adhesion molecule (EpCAM), said peptides being easy to produce by chemical synthesis or a genetic engineering method. [Solution] By improving phage...  
WO/2014/040384A1
A complex microbial flora, the application of same in preparing a textile fiber, a cellulose for use as an additive, and a biological bacterial solution pulp, and application methods therefor. The complex microbial flora comprises Bacill...  
WO/2014/040395A1
A complex microbial flora, an application of same, and an application method therefor in preparing a textile fiber, a cellulose for use as an additive, and a biological bacterial solution pulp. The complex microbial flora comprises Acine...  
WO/2014/040955A1
The invention relates to a method for producing L-cysteine and its derivatives L-cystine and thiazolidine by fermenting a cysteine-producing microorganism strain in a fermentation medium. The invention is characterized in that L-methioni...  
WO/2014/040377A1
An Acinetobacter lwoffii strain, uses of the strain in preparing cellulose for textile and addictive and bio-bacterial liquid pulping, and methods of application are provided. The Acinetobacter lwoffii strain is deposited under CGMCC No....  
WO/2014/042237A1
The purpose of the present invention is to provide a novel protein that can be used for a variety of purposes and has saccharide oxidase activity. The present invention provides a protein having the following physicochemical properties. ...  
WO/2014/042076A1
The present invention addresses: the problem of providing a plant-derived carbon source that is modified for the purpose of producing a high molecular weight polyhydroxyalkanoate that has excellent processing characteristics; and the pro...  
WO/2014/040390A1
Provided are a complex microbial flora and an application method therefor in preparing a textile fiber, a cellulose for use as an additive, and a biological bacterial solution pulp. The complex microbial flora comprises Bacillus sp. of d...  
WO/2014/043591A1
This invention relates to the biosynthesis of organic acids in genetically modified microorganisms. More specifically, this invention provides genetically modified microorganisms that are particularly tolerant to organic acids at low pH ...  
WO/2014/040393A1
Provided are a complex microbial flora and an application method therefor in preparing a textile fiber, a cellulose for use as an additive, and a biological bacterial solution pulp. The complex microbial flora comprises Bacillus sp. of d...  
WO/2014/038879A1
The present invention provides an improved production method for a capsular polysaccharide having the pneumococcal serotype. The production method according to the present invention comprises a step of additionally culturing a microbial ...  
WO/2014/039879A1
Provided herein are genetically engineered microbes that include at least a portion of a carbon fixation pathway, and in one embodiment, use molecular hydrogen to drive carbon dioxide fixation. In one embodiment, the genetically engineer...  
WO/2014/039940A1
Provided is a Ralstonia eutropha cell which is able to form at least one rhamnolipid, wherein the cell has ben transfected with at least one vector comprising (a) rhlA, rhlB and rhlC genes from Pseudomonas aeruginosa; and (b) xylA, xylB,...  
WO/2014/038639A1
[Problem] To provide, in order to manufacture cells to transplant into patients with corneal endothelial failure, a medium used to culture corneal endothelial cells obtained from human corneal tissue and grow said cells while maintaining...  
WO/2014/038599A1
A novel method is provided which is able to manufacture an artificial skin model including dendric cells. In the method for manufacturing the artificial skin model, coated cells are cultured whose cell surface is coated with a coating co...  
WO/2014/036946A1
The present invention provides a rice brown planthopper resistance gene bph9 which has a nucleotide sequence shown as SEQ ID NO: 1 and a cDNA sequence shown as SEQ ID NO: 2, and the encoding protein and use thereof. The present invention...  
WO/2014/037912A3
The present disclosure relates to an architecture of energy redistribution that can sustain the increased formation of cofactors like NADH/NADPH and key metabolites like pyruvate that are implicated in the production of isobutanol throug...  
WO/2014/039060A1
The present application relates to recombinant microorganisms comprising biosynthetic pathways and methods of using said recombinant microorganisms to produce various beneficial metabolites, such as isobutanol. In various aspects of the ...  
WO/2014/038822A1
The present invention relates to Paecilomyces variotii var. brunneolus GPP1101B (microorganism deposit number KCTC119938BP) isolated during a ginseng fermentation process, and a preparation using the same. According to the present invent...  
WO/2014/034884A1
The present invention provides a cryopreservative agent which enables the three-dimensional culture of cells. The present invention provides a hydrogel produced by the intermolecular crosslinking of an amphoteric electrolyte polymer in a...  
WO/2014/033638A3
The present invention relates to a bio-inoculant and its use for reduction of contaminants in effluents from processing industries.  
WO/2014/036152A1
A stereospecific enzyme in C. autoethanogenum permits the conversion of racemic propanediol to acetone and/or propionaldehyde. Entantiomeric starting materials lead to different products. If desired, the products may be reduced to form a...  
WO/2014/033574A3
The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The present invention also relates to the person...  
WO/2014/033345A1
The invention relates to a microbial consortium comprising a Clostridium roseum strain with Spanish Type Culture Collection access number CECT8187 and a Streptomyces sp. strain with Spanish Type Culture Collection access number CECT8185....  
WO/2014/036140A3
The present disclosure generally relates to microorganisms (e.g., non-naturally occurring microorganisms) that comprise one or more polynucleotides coding for enzymes in a pathway that catalyze a conversion of a carbon source (e.g., a fe...  
WO/2014/032314A1
A method for producing biological humic acid comprises: using palm byproducts empty fruit bunch and palm oil slime as raw materials, adding biological humic acid conversion agent, and performing high-temperature aerobic fermentation at 5...  
WO/2014/034147A1
[Problem] To provide a novel therapeutic agent or preventive agent for photosensitivity or a cosmetic. [Solution] A compound represented by general formula; and a medicinal composition or cosmetic composition having therapeutic and/or pr...  
WO/2014/033018A1
The present invention relates to a yeast cell comprising: a) a disruption of deletion of one or more gene native in the yeast cell coding for an enzyme having glycerolphosphate dehydrogenase (GPD) activity; b) an exogenous polynucleotide...  
WO/2014/035289A9
Provided is a pharmaceutical composition for growth induction in blood vessel tissue which contains purified plasmid DNA encoding a vascular endothelial growth factor (VEGF) and pharmaceutically acceptable excipients that include a cr...  
WO/2014/034456A1
Provided is a simple method for producing a cell concentrate (excluding human blood) in little time, without losing cells and without burdening superfluous cells. Provided is a method for producing a cell concentrate, the method using a ...  
WO/2014/033019A1
The present invention relates to a yeast cell comprising: a) a disruption of deletion of one or more gene native in the yeast cell coding for an enzyme having glycerolphosphate dehydrogenase (GPD) activity; b) an exogenous polynucleotide...  
WO/2014/032375A1
Disclosed are a lactobacillus plantarum having function of cadmium expelling and the use thereof. The lactobacillus plantarum CCFM8610 of the present invention has acid resistance and good ability of resisting and adsorbing cadmium ions ...  
WO/2014/035289A1
Provided is a pharmaceutical composition for growth induction in blood vessel tissue which contains purified plasmid DNA encoding a vascular endothelial growth factor (VEGF) and pharmaceutically acceptable excipients that include a cr...  
WO/2014/033330A1
A method is provided for evaluating agents for the treatment of different intestinal motility disorders, using distinct methodological parts related to musculature and nerves of the GI tract which communicate with the brain. In particula...  
WO/2014/035925A1
Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway (MMP) that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to inc...  
WO/2014/034146A1
Disclosed are: a cell culture module wherein a substance with an arbitrary size can be taken in and out at an arbitrary position in the module; a cell culture module which can be highly liquid-tightly or air-tightly connected to a fluid ...  
WO/2014/033307A1
An isolated Lactobacillus mucosae (DPC6426) strain deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 27th July 2012 under NCIMB Deposit Accession No. 42015.  
WO/2014/036438A3
The present invention provides Brucella vaccines that protect against Brucella infections and brucellosis. These vaccines can provide cross-resistance to protect against infections by other Brucella strains. Also provided are the Brucell...  
WO/2014/030653A1
Provided is a hydrogen generator wherein the entire surface of a photocatalyst, which has a complicated structure, can be irradiated with light. This hydrogen generator comprises water (40), a photocatalyst (20) and a light source (30) t...  
WO/2014/029783A1
The present invention relates to a process for freeze drying a bacteria-containing concentrate. Further, the present invention relates to the freeze dried concentrates per se.  
WO/2014/030096A3
Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprisi...  
WO/2014/030841A3
With respect to Hydrodictyon sp. algae of which a mass production method has not been reported, among freshwater algae, the present invention provides an economical and efficient method for the massive culturing, high quality biomass, cu...  
WO/2014/030774A1
The present invention addresses the problem of providing a medium, preferably a chemically synthesized medium, that has a capability, equal to or more than YPD medium, of imparting a proliferation ability to a yeast to thereby provide a ...  
WO/2014/029758A1
The present invention relates to a process for optimizing the storage stability of a freeze dried bacteria-containing product obtained from a bacteria-containing concentrate, wherein the process is carried out at a pressure which will pr...  
WO/2014/030644A1
 Provided are: a transformant of a Schizosaccharomyces Pombe (S. Pombe) mutant with which β-glucosidase can be produced and collected without requiring a complicated isolation step; and a vector useful for transforming Schizosaccharom...  
WO/2014/030090A1
A method for metabolizing PPO-inhibiting herbicides, comprising contacting the PPO-inhibiting herbicide with a CytP450 monooxygenase, is provided. Transgenic plants comprising the CytP450 monooxygenase polypeptide of the invention, as we...  
WO/2014/031831A1
The invention relates to the development of microorganisms capable of producing fermentation products via an engineered pathway in the microorganisms. The invention also relates to microorganisms with improved cell viability and methods ...  
WO/2014/029498A1
The present invention provides dimers and sulfonyl dimers of the compound of formula (I) having antibacterial activities.  
WO/2014/030726A1
The invention pertains to a protein production accelerator that makes it possible to add polysaccharides to an animal cell culture medium containing serum or serum replacement and greatly increase the amount of the desired protein produc...  

Matches 701 - 750 out of 84,147